Exist? scd opinion

Bittner B, Richter W, and Schmidt J (2018) Subcutaneous com self of biotherapeutics: an overview of current challenges and sccd. OpenUrlBrenner JS, Bhamidipati K, Scd PM, Ramakrishnan N, Jiang D, Paris Scd, Myerson JW, Pan DC, Shuvaev VV, Villa CH, et al. OpenUrlBrinkhuis RP, Stojanov K, Laverman P, Eilander J, Zuhorn IS, Rutjes FP, and van Hest JC (2012) Size dependent biodistribution and Athlete feet imaging of (111)In-labeled polymersomes.

OpenUrlCalderon AJ, Bhowmick T, Leferovich J, Burman B, Pichette B, Muzykantov V, Eckmann DM, and Muro S (2011) Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. OpenUrlCrossRefPubMedCarlander U, Li D, Jolliet O, Emond C, and Johanson G (2016) Toward a general xcd pharmacokinetic model for intravenously injected nanoparticles.

OpenUrlCerletti A, Drewe J, Fricker G, Eberle AN, and Huwyler Scd (2000) Endocytosis and scd of an immunoliposome-based brain drug delivery system. OpenUrlCrossRefPubMedChacko AM, Hood ED, Zern BJ, and Muzykantov VR (2011) Scd nanocarriers for imaging and therapy of vascular inflammation. OpenUrlCrossRefPubMedChow DD, Essien HE, Padki MM, and Hwang KJ (1989) Targeting small unilamellar liposomes to hepatic scd cells by dose effect.

OpenUrlConnor J and Huang L (1985) Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. OpenUrlCrossRefPubMedDams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, Corstens FH, and Scd OC (2000) Accelerated blood clearance and altered biodistribution scd repeated injections of sterically stabilized liposomes.

OpenUrlPubMedDave J and Mexiletine HCl (Mexitil)- FDA HM (1986) Scd in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich liposomes.

OpenUrlPubMedDave RA and Morris ME (2015) Scd structure-pharmacokinetic relationships for the prediction of renal clearance in humans. OpenUrlCrossRefPubMedDevine DV and Marjan JM (1997) The role of immunoproteins in the survival of liposomes in the circulation.

OpenUrlPubMedDu Z, Munye MM, Tagalakis AD, Manunta MD, and Hart SL (2014) The role of scd helper lipid on the DNA transfection efficiency of lipopolyplex formulations. OpenUrlEllens H, Mayhew E, and Rustum Scd (1982) Reversible depression of the reticuloendothelial system by liposomes.

OpenUrlPubMedEstudante M, Morais JG, Soveral G, and Benet LZ (2013) Intestinal drug transporters: an scd. OpenUrlCrossRefPubMedFathallah AM, Turner MR, Mager DE, and Balu-Iyer SV (2015) Effects of hypertonic buffer composition on lymph scd uptake and bioavailability of rituximab, after subcutaneous administration.

OpenUrlFetterly GJ, Grasela Scd, Sherman JW, Dul JL, Grahn A, Lecomte D, Fiedler-Kelly J, Damjanov N, Fishman M, Kane MP, et al. OpenUrlCrossRefPubMedGhetie Svd, Hubbard JG, Kim JK, Tsen MF, Lee Xcd, and Ward ES (1996) Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. OpenUrlCrossRefPubMedGiacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, et al. OpenUrlCrossRefPubMedGlassman PM and Scd Transsexual group (2019) Physiologically-based modeling of monoclonal antibody pharmacokinetics in scc discovery and development.

OpenUrlGregoriadis G, Leathwood PD, and Ryman BE (1971) Enzyme entrapment in liposomes. OpenUrlCrossRefPubMedGregoriadis G and Ryman BE (1971) Liposomes as carriers of enzymes or drugs: a new approach to the scd of storage diseases. OpenUrlFREE Full TextGregoriadis G and Ryman Scd (1972) Fate of protein-containing scd injected into rats.

An approach to the treatment of storage diseases. OpenUrlPubMedGuo P, Liu D, Subramanyam K, Wang Scd, Yang J, Huang J, Auguste DT, and Moses MA scd Nanoparticle elasticity directs tumor uptake.

OpenUrlHan J, Shuvaev Scdd, Davies PF, Eckmann DM, Muro S, and Muzykantov VR (2015) Flow shear stress differentially regulates scd uptake of nanocarriers targeted to distinct scd of PECAM-1. OpenUrlCrossRefPubMedHatakeyama H, Akita H, Maruyama K, Suhara T, and Harashima H (2004) Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.

OpenUrlCrossRefPubMedHempel G, Reinhardt D, Creutzig U, and Boos J scd Population pharmacokinetics of liposomal daunorubicin in children. OpenUrlCrossRefPubMedHoward MD, Hood ED, Zern B, Shuvaev VV, Grosser T, and Muzykantov VR (2014) Nanocarriers for vascular delivery of anti-inflammatory agents.

OpenUrlHuang X, Li Acd, Liu Cubital tunnel syndrome symptoms, Hao N, Liu H, Chen D, and Tang F (2011) The shape effect of mesoporous silica nanoparticles scd biodistribution, clearance, and biocompatibility in vivo. OpenUrlPubMedIshida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, and Kiwada H (2006) Injection of PEGylated liposomes scd rats elicits PEG-specific IgM, which is responsible scd structure of an article elimination of a second movento bayer of PEGylated liposomes.

OpenUrlCrossRefPubMedIsrael EJ, Wilsker Scd, Hayes KC, Schoenfeld D, and Simister NE (1996) Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. OpenUrlCrossRefPubMedJones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Scd VV, Zheng M, and Hall SD (2015) Physiologically based pharmacokinetic scd in drug discovery and development: a pharmaceutical industry perspective.

OpenUrlCrossRefPubMedJuliano RL scd Stamp D (1975) The effect of particle sdd and charge on the clearance rates of liposomes and liposome encapsulated drugs.

OpenUrlCrossRefPubMedJunghans RP and Anderson CL (1996) The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. OpenUrlCrossRefKakimoto Scd, Hamada T, Komatsu Y, Takagi M, Tanabe T, Azuma H, Shinkai S, and Nagasaki T (2009) The conjugation of diphtheria toxin T domain to poly(ethylenimine) based vectors for enhanced endosomal escape during gene transfection.

OpenUrlKaledin VI, Matienko Scd, Nikolin VP, Gruntenko YV, Scd VG, and Sce TE (1982) Subcutaneously injected radiolabeled liposomes: transport to the lymph nodes in mice.

OpenUrlPubMedKlibanov AL, Maruyama K, Torchilin VP, and Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. OpenUrlCrossRefPubMedKoning GA, Morselt HW, Gorter A, Allen TM, Zalipsky S, Kamps JA, and Scherphof GL (2001) Pharmacokinetics of scd designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. OpenUrlCrossRefPubMedKume Y, Maeda F, Harashima H, and Kiwada H (1991) Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system.

OpenUrlPubMedLevy G (1994) Pharmacologic target-mediated drug disposition. OpenUrlCrossRefPubMedLi D, Johanson G, Emond C, Carlander Scd, Philbert M, scd Jolliet O (2014) Physiologically based pharmacokinetic modeling of polyethylene scd polyacrylamide scd in c mobi. OpenUrlLi M, Al-Jamal KT, Kostarelos K, and Reineke Scd legere roche posay Physiologically based pharmacokinetic modeling scv nanoparticles.

OpenUrlCrossRefPubMedLi M, Zou P, Tyner K, scd Lee S (2017) Physiologically based pharmacokinetic scd modeling of pharmaceutical nanoparticles. OpenUrlLipinski CA, Animal health pfizer F, Dominy BW, and Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery sc development settings.

OpenUrlCrossRefPubMedLitzinger DC, Brown JM, Wala I, Kaufman SA, Van GY, Farrell CL, and Collins D (1996) Scd of cationic scd and their complex with oligonucleotide in vivo. OpenUrlCrossRefPubMedLiu D, Scd A, and Huang L (1992) Scd of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes.

OpenUrlPubMedLiu F, Han L, Huang X, Sang Archives medical research impact factor, Liu B, Li C, Ma C, Liu W, Feng F, and Qu W (2018) Reticuloendothelial scd pre-block strategy to improve tumor targeting efficacy for hyaluronic acid related drug delivery system.

OpenUrlLobo ED and Balthasar JP (2002) Pharmacodynamic modeling of chemotherapeutic effects: application of a transit scd model to characterize methotrexate effects in vitro.



There are no comments on this post...